Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community.
The global allergy community strongly believes that the 11th revision of the International Classification of Diseases (ICD-11) offers a unique opportunity to improve the classification and coding of hypersensitivity/allergic diseases via inclusion of a specific chapter dedicated to this disease area to facilitate epidemiological studies, as well as to evaluate the true size of the allergy epidemic. In this context, an international collaboration has decided to revise the classification of hypersensitivity/allergic diseases and to validate it for ICD-11 by crowdsourcing the allergist community. After careful comparison between ICD-10 and 11 beta phase linearization codes, we identified gaps and trade-offs allowing us to construct a classification proposal, which was sent to the European Academy of Allergy and Clinical Immunology (EAACI) sections, interest groups, executive committee as well as the World Allergy Organization (WAO), and American Academy of Allergy Asthma and Immunology (AAAAI) leaderships. The crowdsourcing process produced comments from 50 of 171 members contacted by e-mail. The classification proposal has also been discussed at face-to-face meetings with experts of EAACI sections and interest groups and presented in a number of business meetings during the 2014 EAACI annual congress in Copenhagen. As a result, a high-level complex structure of classification for hypersensitivity/allergic diseases has been constructed. The model proposed has been presented to the WHO groups in charge of the ICD revision. The international collaboration of allergy experts appreciates bilateral discussion and aims to get endorsement of their proposals for the final ICD-11.
Hospital Sírio Libanês, São Paulo, Brazil.
L K
LK
Tanno
Section of Allergy and Clinical Immunology, Imperial College London, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.
M A
MA
Calderon
Kaiser-Permanente Southern California Regional Allergy-Immunology Laboratory, Los Angeles, CA, USA.|International Health Terminology Standards Development Organization, Los Angeles, CA, USA.
B J
BJ
Goldberg
Polyclinique de l'Ormeau, Tarbes, France.
J
J
Gayraud
Allergy Unit, Department of Dermatology, University Hospital Basel, Basel, Switzerland.
A J
AJ
Bircher
Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
T
T
Casale
Division of Allergic Diseases, Mayo Clinic, Rochester, MN, USA.
J
J
Li
Allergy and Clinical Immunology Department, Centro Medico Docente La Trinidad, Caracas, Venezuela.
M
M
Sanchez-Borges
Division of Immunology Research, Department of Pediatrics, Children's Mercy Hospitals & Clinics, Kansas City, MO, USA.
L J
LJ
Rosenwasser
Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
R
R
Pawankar
Centre for Paediatrics and Child Health, Institute of Human Development, University of Manchester, Manchester, UK.|Department of Allergy, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
N G
NG
Papadopoulos
University Hospital of Montpellier, Montpellier, France.|Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
P
P
Demoly
D000486:Allergy and Immunology; D032921:Consensus; D063045:Crowdsourcing; D006801:Humans; D006967:Hypersensitivity / Q000145:classification*; D038801:International Classification of Diseases
International Classification of Diseases; World Health Organization; allergic diseases; classification; hypersensitivity diseases